SoftBank Corp
TSE:9434
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
SoftBank Corp
Cash & Cash Equivalents
SoftBank Corp
Cash & Cash Equivalents Peer Comparison
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
SoftBank Corp
TSE:9434
|
Cash & Cash Equivalents
ÂĄ2T
|
CAGR 3-Years
8%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
KDDI Corp
TSE:9433
|
Cash & Cash Equivalents
ÂĄ887.2B
|
CAGR 3-Years
3%
|
CAGR 5-Years
34%
|
CAGR 10-Years
15%
|
|
SoftBank Group Corp
TSE:9984
|
Cash & Cash Equivalents
ÂĄ6.2T
|
CAGR 3-Years
10%
|
CAGR 5-Years
10%
|
CAGR 10-Years
12%
|
|
Okinawa Cellular Telephone Co
TSE:9436
|
Cash & Cash Equivalents
ÂĄ3.2B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
0%
|
|
Accrete Inc
TSE:4395
|
Cash & Cash Equivalents
ÂĄ1.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
|
Japan Communications Inc
TSE:9424
|
Cash & Cash Equivalents
ÂĄ2.5B
|
CAGR 3-Years
35%
|
CAGR 5-Years
31%
|
CAGR 10-Years
0%
|
See Also
What is SoftBank Corp's Cash & Cash Equivalents?
Cash & Cash Equivalents
2T
JPY
Based on the financial report for Mar 31, 2024, SoftBank Corp's Cash & Cash Equivalents amounts to 2T JPY.
What is SoftBank Corp's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
16%
Over the last year, the Cash & Cash Equivalents growth was -3%. The average annual Cash & Cash Equivalents growth rates for SoftBank Corp have been 8% over the past three years , 16% over the past five years .